Form 4: Clene Inc. Director David J. Matlin Acquires Stock Options
SEC Form 4 Filing
Director David J. Matlin reports acquisition of stock options in Clene Inc. on June 7, 2024.
Summary
- David J. Matlin, a director of Clene Inc., reported the acquisition of 65,723 stock options on June 7, 2024.
- The options were granted under the Clene Inc. Amended 2020 Stock Plan.
- The exercise price is $0.37 per share, and the options vest immediately upon grant.
- The expiration date for the options is June 6, 2034.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing regarding stock option grants, which is neutral in sentiment.
Positives
- The immediate vesting of the options could incentivize the director to work towards the company's success.
Industry Context
Stock option grants are a common practice in the biotechnology industry to incentivize executives and directors.
Stakeholder Impact
- The acquisition of stock options by a director could align their interests with those of the shareholders.
Key Dates
| Date | Description |
|---|---|
| 06/07/2024 | Date of transaction: David J. Matlin acquired stock options. |
| 06/06/2034 | Expiration date of the stock options. |
| 06/10/2024 | Date of report filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.